USPTO serial 79422449
AM06
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- SALES, HEATHER ALISON
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AM06?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dennis S. Prahl
Dennis S. Prahl Ladas & Parry LLP, 1040 Avenue of the Americas, 5th FloorNew York, NY 10018-3738United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cultures of microorganisms for medical or veterinary use; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of pain, cancer and tumors; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia and hypothyroidism; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of gastro-intestinal diseases; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; Drugs for medical purposes, namely, pharmaceutical anxiolytic medications; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of liver diseases and disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of blood disorders, inflammation, sepsis and alopecia; Drugs for medical purposes, namely, psychiatric pharmaceutical preparations for the prevention and treatment of mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; probiotic preparations for medical use; medicinal drinks; dietary supplements to stimulate the growth of probiotics; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional supplements; food for babies; none of the foregoing containing any ingredients from the cannabis sativa L. plant or its extracts or derivatives | ACTIVE | — |
| 029 | Fruits, tinned; cheese; milk; milk products excluding ice cream, ice milk and frozen yogurt; milk beverages, milk predominating; soya milk being milk substitute; seaweed extracts for food; Tofu products, namely, tofu, tofu-based snack food, tofu patties and tofu skin; fruit-based snack food; snack food, fruit and vegetable-based; none of the foregoing containing any ingredients from the cannabis sativa L. plant or its extracts or derivatives | ACTIVE | — |
| 030 | Cocoa; coffee; tea; biscuits; high-protein cereal bars; bread; ice cream; pastries; Confectionery, namely, frozen confectionery, almond confectionery, chocolate confectionery, iced confectionery, nut confectionery, peanut confectionery and confectionery made of sugar; Confectionery, namely, cake, fruit jelly candy; frozen yogurt; yogurt-covered fruit, Dessert mousses; flavored jelly crystals for making jelly confectionery; honey; none of the foregoing containing any ingredients from the cannabis sativa L. plant or its extracts or derivatives | ACTIVE | — |
| 032 | Whey beverages; Non-alcoholic beverages containing fruit juices; Non-alcoholic beverages with tea flavor; Non-alcoholic malt beverages; Non-alcoholic carbonated beverages; Non-alcoholic beer-flavored beverages; Non-alcoholic water-based beverages; Non-alcoholic beverages flavored with coffee; Non-alcoholic drinks made from seaweed; Aloe vera beverages, non-alcoholic; Honey-based beverages, non-alcoholic; fruit beverages; fruit juice; Flavored protein-enriched water beverages; Non-alcoholic vegetable juice beverages; Green vegetable juice beverages; protein-enriched sports beverages; smoothies; plant-based beverages, namely, non-alcoholic fruit juice beverages; Preparations for making non-alcoholic fruit-flavored beverages; Preparations for making non-alcoholic carbonated beverages; none of the foregoing containing any ingredients from the cannabis sativa L. plant or its extracts or derivatives | ACTIVE | — |
| 035 | Advertising services; online advertising on a computer network; commercial administration of the licensing of the goods and services of others; market research studies; commercial information; import-export agency services; sales promotion for others; marketing services; provision of an online marketplace for buyers and sellers of goods and services; Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; none of the featured goods containing any ingredients from the cannabis sativa L. plant or its extracts or derivatives | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Guangzhou Zhiyi Biotechnology Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 032
- Other trademarks in Class 035
- Similar marks named AM06
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 6, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Oct 26, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 23, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 23, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 28, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 24, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 13, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 12, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 28, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 27, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 24, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |